Method for Measuring Fibroblast Growth Factor-23 and Reagent Therefor
US-2024402163-A1 · Dec 5, 2024 · US
US9297799B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9297799-B2 |
| Application number | US-81356306-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 11, 2006 |
| Priority date | Jan 11, 2005 |
| Publication date | Mar 29, 2016 |
| Grant date | Mar 29, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a method for measuring oocyst of protozoa, such as Cryptosporidium , in an environment sample with high sensitivity at low cost within a short period of time; and a detecting reagent for use therein. Magnetic fine particles of 5 to 500 nm particle diameter having, immobilized thereto, binding factors for specific recognition of oocyst are added to an analyte containing a protozoan oocyst to form oocyst/binding factor/magnetic fine particle complexes by using a binding reaction to the oocyst, the formed complexes are recovered by a magnetic separation, and the protozoan oocysts contained in the complexes are assayed. Further, there is provided, for conducting the above method, a reagent for detecting protozoan oocysts comprising magnetic fine particles of 5 to 500 nm particle diameter having, immobilized thereto, antibodies against oocysts or binding factors for recognizing the antibodies.
Opening claim text (preview).
The invention claimed is: 1. A method for measuring Cryptosporidium parvum oocysts in water, which comprises: adding magnetic fine particles of 150 to 500 nm particle diameter, which have an antioocyst antibody for specifically recognizing Cryptosporidium parvum oocysts immobilized thereto, to an aqueous analyte containing Cryptosporidium parvum oocysts to form complexes of the Cryptosporidium parvum oocysts with the magnetic fine particles through the antioocyst antibody, wherein the magnetic fine particles are magnetic fine particles having stimuli-responsive upper critical solution temperature (UCST) polymers immobilized thereto; recovering the thus formed Cryptosporidium parvum oocyst/antioocyst antibody/magnetic fine particle complexes by a magnetic separation; and counting the number of Cryptosporidium parvum oocysts. 2. The method for measuring protozoan oocysts according to claim 1 , wherein the Cryptosporidium parvum oocyst/antioocyst antibody/magnetic fine particle complexes are Cryptosporidium parvum oocyst/antioocyst antibody/magnetic fine particle complexes formed by adding magnetic fine particles having the antioocyst antibody immobilized thereto to the analyte. 3. The method for measuring protozoan oocysts according to claim 1 , wherein the antioocyst antibody has a binding factor component specifically recognizing the antioocyst antibody bound thereto (hereinafter referred to as “antioocyst antibody-binding factor component”). 4. The method for measuring protozoan oocysts according to claim 3 , wherein the oocyst/antioocyst antibody/magnetic fine particle complexes are oocyst/antioocyst antibody/antioocyst antibody-binding factor component/magnetic fine particle complexes, which are formed by adding antibodies against oocyst to an analyte to form oocyst/antioocyst antibody complexes, and subsequently adding magnetic fine particles having the antioocyst antibody-binding factor component against the antibody immobilized thereto. 5. The method for measuring protozoan oocysts according to claim 1 , further comprising labeling the magnetic fine particles before adding the magnetic fine particles. 6. The method for measuring protozoan oocysts according to claim 1 , further comprising labeling oocyst/antioocyst antibody/magnetic fine particle complexes after adding the magnetic fine particles. 7. The method for measuring protozoan oocysts according to claim 6 , wherein the labeling is fluorescent labeling. 8. The method for measuring protozoan oocysts according to claim 6 , wherein the labeling is fluorescent labeling.
Protozoa · CPC title
Magnetic particles · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.